Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain BarrierJessica A. Couch, Ryan J. Watts, Yang Yu et al.|Science Translational Medicine|2013Cited by 267
Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in VivoJason D. Burch, Zhonghua Pei, Charles Eigenbrot et al.|Journal of Medicinal Chemistry|2015Cited by 47